Navigation Links
Advances in Science and Treatment of Pain Presented at 25th Annual American Academy of Pain Medicine Meeting January 28 - 31, 2009
Date:1/26/2009

Further Understanding of Pain as a Disease Leads to Innovation in Treatment

GLENVIEW, Ill., Jan. 26 /PRNewswire/ -- The American Academy of Pain Medicine's (AAPM) 2009 Annual Meeting - its 25th Anniversary - will take place in Hawaii this week with over 200 scientific posters, presentations and sessions. More than 750 physicians and other healthcare providers who research pain, or treat patients with pain, will attend.

"Over the last 25 years there has been an unprecedented evolution of pain medicine, science, and practice. Our scientists are discovering the mechanisms that cause injuries and diseases which damage the spinal cord and brain so that in many cases chronic pain becomes a progressive disease, not just a symptom," said incoming AAPM President and Editor-in-Chief of Pain Medicine, Rollin M. Gallagher, MD MPH. "We have also seen an exponential increase in interventions for back pain, migraines, and traumatic injury patients. And there has been incredible progress in developing several different classes of medicines that work at many levels of the body, spinal cord, and brain to effectively treat pain, including medications with decreased abuse potential."

At this year's meeting, attendees will have access to latest research on the most innovative treatments in a multitude of therapeutic areas, as well as attend sessions to learn more about war and pain, and about advancements in pain management in Pacific Rim countries such as Australia and China.

"With the progress made in global pain medicine research and care, it is the perfect time to converge all approaches to help achieve the best outcomes for patients," Gallagher concluded.

All presentations at AAPM's 25th Annual Meeting are embargoed until the time and date of presentation. All times listed are Hawaii-Aleutian Standard Time (HAST). Following are highlighted plenary sessions and posters:

    Thursday, January 29, 2009 7:00 AM -8:00 AM HAST
    Coral Ballroom, Hilton Hawaiian Village
    Neuroplasticity and Chronic Pain, Norman Doidge, MD PhD Dsc

    Friday, January 30, 2009 10:00 AM - 11:00 AM HAST
    Coral Ballroom, Hilton Hawaiian Village
    Acupuncture: Historical Perspectives and Emerging Advances
     in Treatment of Pain and Addiction, Jisheng Han, MD

    Saturday, January 31, 2009 10:15 AM - 11:15 AM HAST
    Coral Ballroom, Hilton Hawaiian Village
    WAR and PAIN: From Battlefield to Back Home
    Chester 'Trip' Buckenmaier, III, MD COL MC and R. Norman Harden, MD

    Wednesday, January 28, 2009 3:30 PM - Thursday, January 29, 2009,
     10:00 AM HAST
    Coral Ballroom Foyer, Hilton Hawaiian Village
    Authors present Jan. 28 from 5-6:30 PM and Jan. 29 from 9-10 AM

    Spinal Cord Stimulation for Chronic Pain, Poster 117
    Spinal Cord Stimulation for Chronic Pain Review, Poster 121
    Peripheral Nerve Stimulation Outcomes, Poster 126
    Artery of Adamkiewcz and Interventional Pain Management, Poster 135
    Sinergy Treatment for Sacroiliac Joint Pain, Poster 139
    Variations in Epidural Steroid Injections, Poster 142
    Interventional Treatment for Chronic Migraine, Poster 146
    Pain Management in Pediatric Cancer Patients, Poster 153
    Interventional Treatment for Intractable Migraine, Poster 155
    Acute Treatment of Intractable Migraine, Poster 157
    Chronic Pain and Depression, Poster 175
    GABAergic Interneurons and Chronic Post-Ischemic Pain, Poster 178

    Thursday, January 29, 2009 3:30 PM - Friday, January 30, 2009,
     10:00 AM HAST
    Coral Ballroom Foyer, Hilton Hawaiian Village
    Authors present Jan. 29 from 3:30-5 PM and Jan. 30 from 9-10 AM

    Calcium Channel Blockers Compared for Neuropathic Pain, Poster 181
    Addictive Qualities of Cannabinoid Medication, Poster 193
    Tramadol Outcomes, Poster 197
    Safety, Tolerability and Effectiveness of Duloxetine for
     Fibromyalgia, Poster 204
    Effects of Oral Oxycodone in Recreational Drug Users, Poster 211
    Evaluation of High Dose Opioids in Chronic Pain Patients, Poster 220
    Long Term Opioid Therapy May Suppress Adrenal Corticosteroids, Poster 221
    Catastrophizing About Pain & Enhanced Pro-Inflammatory Pain
     Response Poster 250
    Pain Surveys of Casualties from the Iraq and Afghanistan Wars,
     Posters 252 and 253
    Outcomes of a Community-Based Pain Management Program, Poster 261
    Public Opinion Survey Regarding Prescription Pain Medication, Poster 266
    Prevalence of Chronic Pain, Poster 272
    Headaches in Iraq/Afghanistan Veterans & Trauma/Combat Injury, Poster 273
    Reduction of Opioid/Illicit Drug Abuse & Electronic
     Prescription Monitoring, Poster 274

About the AAPM

For over 25 years, the American Academy of Pain Medicine (AAPM) has been the medical specialty society representing more than 2,200 physicians practicing in the field of pain medicine. The Academy is involved in education, training, advocacy and research in the specialty of pain medicine. Information is available on the practice of pain medicine at www.painmed.org.


'/>"/>
SOURCE American Academy of Pain Medicine
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
2. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
3. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
4. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
5. Thermo Fisher Scientific Advances Gene-Silencing Technology for Life Sciences Research
6. Stem Cell Breakthrough Advances Science Without Ethical Landmines, Says Cardinal
7. Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
8. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
9. Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program
10. CuraGen Advances CR011-vcMMAE into Phase II
11. MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
Breaking Medicine News(10 mins):